BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19809499)

  • 1. Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.
    Salama SA; Kamel MW; Botting S; Salih SM; Borahay MA; Hamed AA; Kilic GS; Saeed M; Williams MY; Diaz-Arrastia CR
    PLoS One; 2009 Oct; 4(10):e7356. PubMed ID: 19809499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential protective effects of estradiol and 2-methoxyestradiol in ischemia reperfusion-induced kidney injury in ovariectomized female rats.
    Hassan E; Allam S; Mansour AM; Shaheen A; Salama SA
    Life Sci; 2022 May; 296():120441. PubMed ID: 35240160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm utilize tumor necrosis factor alpha to shut down a 2-methoxyestradiol nongenomic pathway that accelerates oviductal egg transport in the rat.
    Oróstica ML; Reuquen P; Guajardo-Correa E; Parada-Bustamante A; Cardenas H; Orihuela PA
    Reproduction; 2023 Apr; 165(4):383-393. PubMed ID: 36762768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells.
    Salama SA; Diaz-Arrastia CR; Kilic GS; Kamel MW
    Fertil Steril; 2012 Jul; 98(1):178-84. PubMed ID: 22579131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
    LaVallee TM; Zhan XH; Herbstritt CJ; Kough EC; Green SJ; Pribluda VS
    Cancer Res; 2002 Jul; 62(13):3691-7. PubMed ID: 12097276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two faces of the estrogen metabolite 2-methoxyestradiol in vitro and in vivo.
    Lee JS; Kim YK; Yang H; Kang HY; Ahn C; Jeung EB
    Mol Med Rep; 2015 Oct; 12(4):5375-82. PubMed ID: 26165333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Methoxyestradiol ameliorates metabolic syndrome-induced hypertension and catechol-O-methyltransferase inhibited expression and activity in rats.
    Azhar AS; Zaher ZF; Ashour OM; Abdel-Naim AB
    Eur J Pharmacol; 2020 Sep; 882():173278. PubMed ID: 32544503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.
    Salama SA; Nasr AB; Dubey RK; Al-Hendy A
    J Soc Gynecol Investig; 2006 Dec; 13(8):542-50. PubMed ID: 17088081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase.
    Sharan C; Halder SK; Thota C; Jaleel T; Nair S; Al-Hendy A
    Fertil Steril; 2011 Jan; 95(1):247-53. PubMed ID: 20736132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green tea extract inhibition of human leiomyoma cell proliferation is mediated via catechol-O-methyltransferase.
    Zhang D; Rajaratnam V; Al-Hendy O; Halder S; Al-Hendy A
    Gynecol Obstet Invest; 2014; 78(2):109-18. PubMed ID: 24942317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms.
    Salama S; Diaz-Arrastia C; Patel D; Botting S; Hatch S
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):231-9. PubMed ID: 21392897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
    Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers.
    Tolba MF; Omar HA; Hersi F; Nunes ACF; Noreddin AM
    Mol Cell Endocrinol; 2019 May; 488():79-88. PubMed ID: 30904591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
    Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
    Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
    Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
    Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
    Hassan MH; Salama SA; Arafa HM; Hamada FM; Al-Hendy A
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3949-57. PubMed ID: 17635941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
    Al-Hendy A; Salama SA
    J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
    Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
    Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation.
    Afrin S; El Sabeh M; Islam MS; Miyashita-Ishiwata M; Malik M; Catherino WH; Akimzhanov AM; Boehning D; Yang Q; Al-Hendy A; Segars JH; Borahay MA
    Pharmacol Res; 2021 Oct; 172():105856. PubMed ID: 34461224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.